FDA's vac­cine ad­comm to re­view first fe­cal trans­plant to treat C. dif­fi­cile in­fec­tions

Back in 2018, Swiss drug­mak­er Fer­ring Phar­ma­ceu­ti­cals made a big bet on Min­neso­ta-based Re­bi­otix, buy­ing up the com­pa­ny for its ex­per­i­men­tal poop-based drug im­plant to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER